Drug-drug interaction between levetiracetam and non-vitamin K antagonist anticoagulants

被引:23
作者
Mathy, Francois-Xavier [1 ]
Dohin, Elisabeth [2 ]
Bonfitto, Francois [1 ]
Pelgrims, Barbara [2 ]
机构
[1] UCB Pharma, Chemin Foriest, B-1420 Braine Lalleud, Belgium
[2] UCB Pharma, 60,Allee Rech, B-1070 Brussels, Belgium
关键词
D O I
10.1093/eurheartj/ehy780
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This commentary refers to 'The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation', by Steffel et al., 2018, pages 1330-1393.
引用
收藏
页码:1571 / 1571
页数:1
相关论文
共 5 条
[1]   Differences in the transport of the antiepileptic drugs phenytoin, levetiracetarn and carbamazepine by human and mouse P-glycoprotein [J].
Baltes, Steffen ;
Gastens, Alexandra M. ;
Fedrowitz, Maren ;
Potschka, Heidrun ;
Kaever, Volkhard ;
Loescher, Wolfgang .
NEUROPHARMACOLOGY, 2007, 52 (02) :333-346
[2]  
Grewal G. K., 2017, MOLECULES, V22
[3]   Comparison of CYP3A4-Inducing Capacity of Enzyme-Inducing Antiepileptic Drugs Using 4β-Hydroxycholesterol as Biomarker [J].
Hole, Kristine ;
Wollmann, Birgit M. ;
Nguyen, Camilla ;
Haslemo, Tore ;
Molden, Espen .
THERAPEUTIC DRUG MONITORING, 2018, 40 (04) :463-468
[4]   Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers [J].
Levy, RH ;
Ragueneau-Majlessi, I ;
Baltes, E .
EPILEPSY RESEARCH, 2001, 46 (02) :93-99
[5]   The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation [J].
Steffel, Jan ;
Verhamme, Peter ;
Potpara, Tatjana S. ;
Albaladejo, Pierre ;
Antz, Matthias ;
Desteghe, Lien ;
Haeusler, Kart Georg ;
Oldgren, Jonas ;
Reinecke, Holger ;
Roldan-Schilling, Vanessa ;
Rowell, Nigel ;
Sinnaeve, Peter ;
Collins, Ronan ;
Camm, A. John ;
Heidbulchel, Hein .
EUROPEAN HEART JOURNAL, 2018, 39 (16) :1330-1393